This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
20
Blood samples will allow the measurement of AFP, LDH and HCG as well as the measurement of testosterone, glucose, cholesterol, triglycerides and bile acids
On these tissues (tumoral and non-tumoral), the investigators will carry out analysis of the bile acid composition by mass spectrometry, molecular characterization by RNAseq, histological characterization and analysis in cell culture
CHU Clermont-Ferrand
Clermont-Ferrand, France
RECRUITINGTo compare bile acid levels in healthy testicular tissues and in tumorous testicular tissues in patients with testicular germ cell tumor
The investigators hypothesis is that bile acid levels are higher in tumor tissues compared to those present in healthy tissues of patients with testicular germ cell tumors, making them a marker of these tumors. Furthermore, the investigators suggest that blood bile acid levels and their composition are a relevant prognostic marker of these tumors.
Time frame: During orchidectomy
Composition of bile acids in healthy and tumor testicular tissues
Time frame: Perioperative
Correlation between blood bile acid levels and survival
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Correlation between blood bile acid levels and the prognostic stage
Time frame: From enrollment to 24 months after the end of treatment
Correlation between bile acid levels and tumor markers
Time frame: From enrollment to 24 months after the end of treatment
Correlation bile acid levels kinetics with the response to chemotherapy
Time frame: From enrollment to 24 months after the end of treatment
Correlation between bile acid level kinetics and survival
Time frame: From enrollment to 24 months after the end of treatment
Analysis of chemosensitivity of tumor cells in vitro
Time frame: From the end of chemotherapy to 24 months after the end of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.